10-20845280-T-G

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2

The NM_006393.3(NEBL):​c.1205A>C​(p.Tyr402Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000523 in 1,586,598 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. Y402Y) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000054 ( 0 hom. )

Consequence

NEBL
NM_006393.3 missense

Scores

1
5
12

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 5.88

Publications

2 publications found
Variant links:
Genes affected
NEBL (HGNC:16932): (nebulette) This gene encodes a nebulin like protein that is abundantly expressed in cardiac muscle. The encoded protein binds actin and interacts with thin filaments and Z-line associated proteins in striated muscle. This protein may be involved in cardiac myofibril assembly. A shorter isoform of this protein termed LIM nebulette is expressed in non-muscle cells and may function as a component of focal adhesion complexes. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
NEBL Gene-Disease associations (from GenCC):
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BS2
High AC in GnomAd4 at 5 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006393.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NEBL
NM_006393.3
MANE Select
c.1205A>Cp.Tyr402Ser
missense
Exon 12 of 28NP_006384.1
NEBL
NM_001377322.1
c.358-32340A>C
intron
N/ANP_001364251.1
NEBL
NM_213569.2
c.358-32340A>C
intron
N/ANP_998734.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NEBL
ENST00000377122.9
TSL:1 MANE Select
c.1205A>Cp.Tyr402Ser
missense
Exon 12 of 28ENSP00000366326.4
NEBL
ENST00000417816.2
TSL:1
c.358-32340A>C
intron
N/AENSP00000393896.2
NEBL
ENST00000482754.1
TSL:5
n.216A>C
non_coding_transcript_exon
Exon 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152136
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000798
AC:
20
AN:
250750
AF XY:
0.0000516
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000927
Gnomad NFE exome
AF:
0.000132
Gnomad OTH exome
AF:
0.000327
GnomAD4 exome
AF:
0.0000544
AC:
78
AN:
1434462
Hom.:
0
Cov.:
28
AF XY:
0.0000433
AC XY:
31
AN XY:
715296
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32816
American (AMR)
AF:
0.00
AC:
0
AN:
44594
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25940
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39436
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85696
European-Finnish (FIN)
AF:
0.000188
AC:
10
AN:
53308
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5712
European-Non Finnish (NFE)
AF:
0.0000570
AC:
62
AN:
1087414
Other (OTH)
AF:
0.000101
AC:
6
AN:
59546
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
152136
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41440
American (AMR)
AF:
0.00
AC:
0
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68014
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000282
Hom.:
0
Bravo
AF:
0.0000227
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000115
AC:
14
EpiCase
AF:
0.0000546
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 28, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The Tyr402Ser variant in NEBL has not been reported in the literature but has be en identified in a Caucasian infant with DCM tested by our laboratory (LMM unpub lished data). This variant has been identified in 1/8600 European American chrom osomes from a broad population by the NHLBI Exome Sequencing Project (http://evs .gs.washington.edu/EVS/). The affected amino acid is not well conserved in evolu tion, suggesting that this change may be tolerated. This is also supported by co mputational predictions (AlignGVGD, PolyPhen2, and SIFT), though this informatio n is not predictive enough to rule out pathogenicity. Additional information is needed to fully assess the clinical significance of the Tyr402Ser variant.

Primary dilated cardiomyopathy Uncertain:1
Mar 09, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces tyrosine, which is neutral and polar, with serine, which is neutral and polar, at codon 402 of the NEBL protein (p.Tyr402Ser). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 45477). This variant has not been reported in the literature in individuals affected with NEBL-related conditions. This variant is present in population databases (rs375569591, gnomAD 0.01%).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
22
DANN
Benign
0.94
DEOGEN2
Benign
0.10
T
Eigen
Benign
0.11
Eigen_PC
Uncertain
0.27
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.80
T
M_CAP
Benign
0.0081
T
MetaRNN
Uncertain
0.48
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.6
L
PhyloP100
5.9
PrimateAI
Uncertain
0.54
T
PROVEAN
Pathogenic
-4.6
D
REVEL
Benign
0.14
Sift
Benign
0.60
T
Sift4G
Benign
0.29
T
Polyphen
0.30
B
Vest4
0.64
MVP
0.49
MPC
0.018
ClinPred
0.048
T
GERP RS
6.0
Varity_R
0.31
gMVP
0.23
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375569591; hg19: chr10-21134209; API